Genetically engineered dendritic cell vaccine (Baylor Research Institute)

基因工程树突细胞疫苗

Report date: 2023/02/04 20:21:30

Base Information

Drug NameGenetically engineered dendritic cell vaccine (Baylor Research Institute)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor Research Institute Llc Anrs

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAnrs Baylor Research Institute Llc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A